Document -
Vironova AB and AstraZeneca are partners in FoRmulaEx, a new Industrial Research Centre receiving 75Million SEK from SSF to work on key development bottlenecks for powerful new medicines
As previously reported on www.vironova.com, Vironova AB, AstraZeneca, Camurus AB and key research groups headed up by Chalmers University of technology, have teamed up in the FoRmulaEx centre, a new multi-disciplinary Industrial Research Centre that has recently received funding of 75M SEK from the Swedish foundation for Strategic Research (SSF). The focus is on complex, oligonucleotide drugs.
go to media item
- License:
- Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: